¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõ¸ð°ø°¢È­Áõ ½ÃÈï ±¸¿ùµ¿ Ä¡·á Ãʱ⿡ °ü¸®ÇØ¿ä

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 
#¼Ûµµ¸ð°ø°¢È­Áõ, #¼Ûµµ¸ð°ø°¢È­ÁõÄ¡·á, #ÇǺο°, #¼ÛµµÇǺο°, #¸ð°ø°¢È­ÁõÄ¡·á, #ÇǺο°Ä¡·á, #¼ÛµµÇǺο°, #¼Ûµµ¸ð°ø°¢È­Áõ ¼Ûµµ¸ð°ø°¢È­Áõ,,¼Ûµµ¸ð°ø°¢È­ÁõÄ¡·á,,ÇǺο°,,¼ÛµµÇǺο°,,¸ð°ø°¢È­ÁõÄ¡·á,,ÇǺο°Ä¡·á,,¼ÛµµÇǺο°,,¼Ûµµ¸ð°ø°¢È­Áõ ¾È³çÇϼ¼¿ä. ¼Ûµµ¸ð°ø°¢È­Áõ ¼Ûµµ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä ¼Ûµµ¸ð°ø°¢È­Áõ ¼Ûµµ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ¼ÛµµÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´ÂÇǺο°, ¼Õ¾ÆÅäÇÇ, Àӽŵε巯±â, È­Æó½ÀÁø, Äݸ°¼ºµÎµå·¯±â, ¸ñ¾ÆÅäÇÇ, »ç¸¶±Í, ¾ó±¼È«Á¶, ¾È¸éÈ«Á¶Áõ, ÆÇ»ó°Ç¼±, ¾ó±¼»ç¸¶±Í, Å¿­, ¼Õ°¡¶ô»ç¸¶±Í, µî°Ç¼±, Áö·ç¼ºÇǺο°Ä¡·á, ¾î¸°À̻縶±Í, ¾Æ±â¾ÆÅäÇÇÇǺο°, ¾ÆÅäÇÇÄ¡·á, ¿øÇüÅ»¸ð, ¹ß»ç¸¶±Í, ¾î¸°¼±, ³óÆ÷¼º°Ç¼±, »çŸ±¸´Ï½ÀÁø, °æÇÇÁõ, ¿©¸§¾ÆÅäÇÇµî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó ¼öÄ¡·á, ³ì¿ë, °ñµµ¹ý°Ë»ç, °æ±ÙÃß³ª¿ä¹ý, ¿µ¾ç±³À°, paraffin, ÇѹæÁ¤½Å¿ä¹ý, °æ¶ôÇâ±â¿ä¹ý, ½½¸µ, ÀιٵðÃøÁ¤, ±¤¿ªµ¿¿ä¹ý, ¼ºÀåÀڱؿä¹ý, ¾È¸éÁ¤Çüħ¼ú, manipulation, ü¿­Áø´Ü(Àü½Å), ºñ¸¸Àüħ, ÀüÀÚ¿ä¹ý, Ȳ·ÃÇص¶ÅÁ¾àħ, ¾óÀ½¿åÁ¶, ü¼ººÐºÐ¼®, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç °æ³² ±èÇؽà »ï°èµ¿, °æ³² â¿ø½Ã ¸¶»êȸ¿ø±¸ ÇÕ¼º1µ¿, ÀüºÏ ÀÍ»ê½Ã Çö¿µµ¿, ÀüºÏ ÀÍ»ê½Ã ¿ëÁ¦µ¿, °æºÏ ¿µÁֽà ¾ÆÁöµ¿, °æ³² ¾ç»ê½Ã »ïÈ£µ¿, Ãæ³² ¿¹»ê±º ½Å¾Ï¸é, Àü³² ¿µ±¤±º ¿°»ê¸é, °æºÏ ºÀÈ­±º ¼Òõ¸é, ÀÎõ µ¿±¸ ⿵µ¿, ºÎ»ê ¼­±¸ ¾Æ¹Ìµ¿2°¡, °æ±â ¾È¼º½Ã »ç°îµ¿, °æ³² â¿ø½Ã ÁøÇر¸ ¿¬µµµ¿, ÀüºÏ ÀüÁֽà ¿Ï»ê±¸ ´Ù°¡µ¿1°¡, °æ³² ¹Ð¾ç½Ã Ãʵ¿¸é, ÃæºÏ ÃæÁֽà ³ëÀº¸é, Àü³² ¸ñÆ÷½Ã ±¤µ¿3°¡, ¿ï»ê ºÏ±¸ ¸íÃ̵¿, °æ±â È­¼º½Ã ±â»êµ¿, ÀüºÏ ¹«ÁÖ±º Àû»ó¸é, ÀüºÏ ±º»ê½Ã ¿Á¼­¸é, °æ±â ¿ëÀνà ¼öÁö±¸ »óÇö2µ¿, ÀÎõ ³²±¸ ÁÖ¾È7µ¿, ºÎ»ê ±ÝÁ¤±¸ ºÎ°î4µ¿, ºÎ»ê Áß±¸ µ¿±¤µ¿3°¡, ÃæºÏ Á¦Ãµ½Ã ÀǸ²µ¿, ÃæºÏ ±«»ê±º ûõ¸é, °æ±â ºÎõ½Ã ¿ø¹Ì±¸ »ó2µ¿, ÀüºÏ Á¤À¾½Ã ½ÅÅÂÀÎÀ¾, ÀüºÏ ±º»ê½Ã ȸÇö¸é, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù ¼Ûµµ¸ð°ø°¢È­ÁõÄ¡·á ãÀ¸½Ã´Â °è»êµ¿, ÀÎõ¼­±¸, »óµ¿, ÇÐÀ͵¿, ¿ëÇöµ¿, Á־ȵ¿, ¿µÈïµµ, ½ÃÈ­, ¸¸¼öµ¿, ÀÎõ³íÇö, µ¿ÀÎõ, °Ë¾Ï, ¹è°ð½Åµµ½Ã, ´ëºÎµµ, ¿Á·Ãµ¿, ¼Û¸²µ¿, ÀÛÀüµ¿, ÀÎõ, ³²µ¿±¸, ¿ëÀ¯µµ, µ¿Ãᵿ, µ¿±¸, ºñºÀ¸é, ¼Ûµµ, µµ¸²µ¿, °¡Á¤µ¿, ¿¬¼ö±¸, Áßµ¿, ÀÎõÁÖ¾È, ¿¬¼öµ¿, ¹è°ð, ¼Û»ê¸é, ¿¬Èñµ¿, °Ë´Ü, ¼Ò·¡Æ÷±¸ µî ¼Ûµµ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿ø¼ÛµµÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. Galli E, Chini L, Nardi S, et al. Use of a specific oral hyposensitization therapy to Dermatophagoides pteronyssinus in children with atopic dermatitis. Allergol Immunopathol (Madr) 1994; 22:18. 2. Papp KA, Bissonnette R, Gooderham M, et al. Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial. BMC Dermatol 2016; 16:15. 3. Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol 2014; 71:116. 4. Saleem MD, Oussedik E, D'Amber V, Feldman SR. Interleukin-31 Pathway and its Role in Atopic Dermatitis: A Systematic Review. J Dermatolog Treat 2017; :1. 5. Eschler DC, Klein PA. An evidence-based review of the efficacy of topical antihistamines in the relief of pruritus. J Drugs Dermatol 2010; 9:992. 6. Hanania NA, Korenblat P, Chapman KR, et al. Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med 2016; 4:781. 7. Bleehen SS, Chu AC, Hamann I, et al. Fluticasone propionate 0.05% cream in the treatment of atopic eczema: a multicentre study comparing once-daily treatment and once-daily vehicle cream application versus twice-daily treatment. Br J Dermatol 1995; 133:592. 8. Michail SK, Stolfi A, Johnson T, Onady GM. Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials. Ann Allergy Asthma Immunol 2008; 101:508. 9. Panduru M, Panduru NM, Sălăvăstru CM, Tiplica GS. Probiotics and primary prevention of atopic dermatitis: a meta-analysis of randomized controlled studies. J Eur Acad Dermatol Venereol 2015; 29:232. 10. Novak N, Bieber T, Hoffmann M, et al. Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J Allergy Clin Immunol 2012; 130:925.
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõ¸ð°ø°¢È­Áõ ½ÃÈï ±¸¿ùµ¿ Ä¡·á Ãʱ⿡ °ü¸®ÇØ¿ä""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀÎõºñ¿° ±¸¿ùµ¿ ½ÃÈï Ä¡·á ¸¶À½¿¡ ½ïµå´Â
´ÙÀ½±Û ÀÎõÁö·ç¼ºÇǺο° ±¸¿ùµ¿ ½ÃÈï ÇÑÀÇ¿ø ÇѹæÀÌ ÁÁ¾Æ
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
172 °ÅÁ¦¿ÁÆ÷ÇÑÀÇ¿ø ¿©¼ººñ¸¸ À̺¥Æ® ½ÃÀÛÇÕ´Ï´Ù 0 3,941 2016-06-02
171 ¸é¿ª·ÂÀ» ³ô¿©ÁÖ´Â ¼ö½ÂÈ­°­ ¾àħ À̺¥Æ® - À±¾Ø±èÇÑÀÇ¿ø 0 2,022 2016-06-02
170 [6¿ù À̺¥Æ®-À̾ȿÂÀåȯ+¹Ì´Ï¿ÂÀåȯ]Á¤ÀÌ¾È ÇÑÀÇ¿ø,Á¾°¢ÇÑÀÇ¿ø,¼­¸°ÇÑ.. 0 3,768 2016-06-02
169 û´ãBSÇÑÀÇ¿ø º½¸ÂÀÌ 4¿ù~6¿ù À̺¥Æ® 0 1,419 2016-05-30
168 Á¸½ºÅ²ÇÑÀÇ¿ø 5~6¿ù À̺¥Æ® 0 2,144 2016-05-30
167 õ¾È±Ô¸²ÇÑÀÇ¿ø ±âºÐÁÁÀº 5~6¿ù À̺¥Æ® 0 1,994 2016-05-30
166 °­¸ªÁö³²ÇÑÀÇ¿ø 6¿ù ÇÑÁ¤ ºñºñ¶ô¸®ÇÁÆà À̺¥Æ®!!(ÇǺÎź·Â/ º¼Ã³Áü/¾ó.. 0 4,287 2016-05-30
165 â¿ø ¸¶»ê ¾ç´ö ¸ÞÆ®·Î½ÃƼ º½º½ ÇÑÀÇ¿ø 6¿ù À̺¥Æ® - ºñ¸¸ ´ÙÀ̾îÆ® .. 3 4,327 2016-05-30
164 ´ëÀü¿©µå¸§Àü¹®ÇÑÀÇ¿ø ÇØÀ²ÇÑÀÇ¿ø °¡Á¤ÀÇ´Þ À̺¥Æ® 1 5,026 2016-05-25
163 ´«¹Ø¶³¸²¿ÏÄ¡°¡ °¡´ÉÇÒ±î 1 6,557 2016-05-25
162 ¾ç»êÇÑÀÇ¿ø, µÎ¹è ¹Ý°ª Ư±ÞÀ̺¥Æ® 0 4,393 2016-05-25
161 ¾ó±¼ÀÇ Àû ¿©µå¸§ ÅðÄ¡! Àá½Ç¿©µå¸§ ÇÑÀÇ¿ø S¾ØºñÇÑÀÇ¿øÀ» ¼Ò°³ÇÕ´Ï´Ù 0 4,701 2016-05-17
160 °­³²ÇǺÎÇÑÀÇ¿ø ¼Ò°³¸¦ Çغ¼±î¿ä 0 1,880 2016-05-17
159 [5¿ùÀ̺¥Æ®]À̾ȴÙÀ̾îÆ® Á¤À̾ÈÇÑÀÇ¿ø, ¼­¸°µ¿ÇÑÀÇ¿ø, Á¾°¢¿ªÇÑÀÇ¿ø, .. 0 3,898 2016-05-03
158 û±¸°æÈñÇÑÀÇ¿ø/ ¾î¹öÀ̳¯ ½º½ÂÀdz¯ º¸¾à À̺¥Æ® 0 1,626 2016-05-03
157 ³­ÀÓÇÑÀÇ¿ø, ºÎºÎ°¡ ÇÔ²²! ³²¼º³­ÀÓ ÇѾà 20% ÇÒÀÎ À̺¥Æ® 0 2,492 2016-05-03
156 ÀÌõ ´ÙÀ̾îÆ® ÇÏ´ÃÅäÀÇ 5¿ù À̺¥Æ® Çà»ç¸¦ ¼Ò°³ÇÕ´Ï´Ù. 0 3,585 2016-05-03
155 (ºÐ´ç¾ÆÀÌÁ¶¾ÆÇÑÀÇ¿ø)5¿ù °¡Á¤ÀÇ ´Þ ÀÛ¾à Àç¹è´ÜÁö üÇè À̺¥Æ®ÇØ¿ä 1 1,722 2016-05-03
154 ¿¹ÀÎÇÑÀÇ¿ø 5¿ùÇÒÀÎÀ̺¥Æ®(°æ¿Á°í/°øÁø´Ü/ÃѸí´Ü/¿ìȲû½Éȯ/À¯¼Ò¾Æ¿ë.. 0 2,958 2016-05-03
153 ¾î¹öÀ̳¯ ¼±¹°Ãßõ! ÇϴþÖÇÑÀÇ¿ø 5¿ù À̺¥Æ® 0 3,439 2016-05-03
31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷